3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis. - Wikidata - awgldk - TriplyDB

3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.

3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.

http://www.wikidata.org/entity/Q50732857

about

Metabolomics of human brain aging and age-related neurodegenerative diseases Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback Changing the face of kynurenines and neurotoxicity: therapeutic considerations Metabolomic biomarkers as strong correlates of Parkinson disease progression Metabolomics and the search for biomarkers in Parkinson's disease metabolic profiling of Parkinson's disease and mild cognitive impairment.Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria.Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases.Advances in non-dopaminergic treatments for Parkinson's disease Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.Advances in Biomarker Research in Parkinson's Disease.Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.Major developments in the design of inhibitors along the kynurenine pathway.Biological functions of selenium and its potential influence on Parkinson's disease.Proteomics and metabolomics in ageing research: from biomarkers to systems biology.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.How important is tryptophan in human health?Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.Serum amino acid profile in patients with Parkinson's disease.Translational approaches to restoring mitochondrial function in Parkinson's disease.Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease.A glimmer of light at the end of the tunnel?Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.

P2860

Q26992344-49ED61D0-2CD2-4D9A-8673-1107557DF319 Q27327204-3CC98347-E290-4C90-AF2E-F456355B44A7 Q28085041-FD4168F6-8FFB-40C7-98EC-A0D4643F4A8F Q29248111-99B6F336-AD76-4DF7-BCF1-B0521AF11297 Q30410511-C981A90A-22AA-44EF-899C-40155EBDC3D2 Q33835701-B5D78A2E-3633-40D1-A722-B1E1D468DC8D Q36056224-C4EE591B-46ED-4583-A76A-9824506309BE Q36121377-5A026F40-926B-4C97-B352-32B271AB54F9 Q36915988-8F1ED862-79F5-4CAF-BC89-9978B270B781 Q37623378-1D03CC19-6080-446E-9CB3-18DE5A5E54E4 Q38218083-2AB6FEDB-49D2-4D70-992D-D4E2DF748612 Q38271572-BBAA45D5-E683-413B-A8D0-C893D61CC4F8 Q38315590-C9551E9C-1251-4380-9112-55EAEFF8FFAA Q38639708-B68BD3CD-8B5A-4A7F-BF5C-A5E725E454BE Q38681599-A2EC59C9-64BC-42B2-B652-FC3149E18D68 Q38719357-DA56672A-A45A-4576-929E-FDF37D537DAA Q38780220-528197BC-13B7-458B-AA38-1C69ED2AA2FD Q38808400-5BF14568-0E86-448A-8839-60562DA2191C Q38935901-D9DADE6B-EC89-4856-B3C5-AD902A4EF353 Q39429374-4D7104A6-FCE5-4028-92B5-750085A44396 Q41666702-AE76CB0D-089B-4139-94C9-B433B914D4F3 Q47627884-CF646BF6-1745-4A8F-AB0F-D107183CFFB0 Q47698588-86E16501-167E-48E4-9BAC-2582C7B8B2FA Q47972723-DAB2972A-FB62-48E9-A1A9-0A671466F221 Q48043375-352DD777-7156-4D69-8C2E-90A423F0A44A Q48232790-402AF339-09DB-4B61-91EC-F0B6C4D81D69 Q48320615-77B4C306-D2F3-4CBD-9A96-95778D52412F Q50045364-3671384E-9D01-4452-9E9B-74E20AD00B00 Q50856979-AEE7AF7B-7EEC-4964-8C46-D2E9C46C1ADB Q51761574-ADBDEF71-7B13-4CE9-A100-8C0385E77717 Q55381445-B845C2BE-8B78-4BF5-B15A-C05D8696D065

P2860

3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.

http://www.wikidata.org/entity/Q50732857

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

3-hydroxykynurenine and other ...... vered by metabolomic analysis.

@en

3-hydroxykynurenine and other ...... vered by metabolomic analysis.

@nl

type

label

3-hydroxykynurenine and other ...... vered by metabolomic analysis.

@en

3-hydroxykynurenine and other ...... vered by metabolomic analysis.

@nl

prefLabel

3-hydroxykynurenine and other ...... vered by metabolomic analysis.

@en

3-hydroxykynurenine and other ...... vered by metabolomic analysis.

@nl

P1433

Q50732857-CBF872F2-C57B-4028-AB9F-1704AA62FEFC

P1476

Q50732857-89C9B368-F2FA-40F9-8116-864231C5FE81

P2093

Q50732857-5E21EEFA-4F29-45E0-9D00-0AFB3BA3F387

Q50732857-7AEFF194-C371-4DD8-ADB3-77A9F7FBAA47

Q50732857-8D2FCD93-26F5-48AC-9448-452578866715

Q50732857-908FC97D-0AEE-4FB5-9874-9801C728CA70

Q50732857-A78F5D56-FB09-4F19-9B52-FB407B9ED095

P2860

Q50732857-010973CF-8CEC-409B-BC09-E6B8BCE40B7B

Q50732857-13811102-9A46-4F58-BE9D-EE0AF98C7CE1

Q50732857-246DAD26-BADA-4117-9779-33A571F924B5

Q50732857-348FF524-8E40-4D04-B789-055F172B5293

Q50732857-34E806E1-865B-438A-9F8A-922793E2E2C1

Q50732857-35CD8E83-55BD-4566-8069-69737274A476

Q50732857-3F7F574F-AF52-4969-B50A-160A76713854

Q50732857-4D7F81B6-D337-473F-AAB7-5E147DB816E1

Q50732857-55458403-672B-43D7-A314-437518B10844

Q50732857-59CE4F66-D183-4B70-8371-51E77CC60686

P304

Q50732857-3AA944E7-5FD0-4AC2-AD48-9CC0930A6ADE

P31

Q50732857-61DA22C9-C160-45D1-AFB0-054760356554

P356

Q50732857-04283DB8-8F78-4A5C-99E8-CC91DD35D41D

P407

Q50732857-B251B498-D277-44E0-B8DA-021AACBAAD49

P433

Q50732857-58BC87FA-B99D-4CFC-9958-5B4AA5B2E6A3

P478

Q50732857-F09C2C5D-BA7A-4870-8A01-ABA09E3919D6

P50

Q50732857-8B5CD525-531B-4242-9B24-B7FD156EA3A0

Q50732857-DBBC4A1B-0DD7-480C-89C7-4B8473F257B3

P577

Q50732857-A1F5DCC8-124C-463F-88F7-03DBC2F6B2C3

P698

Q50732857-E3A66EAA-3500-4164-994D-643B922BFA7C

P921

Q50732857-5D260337-043B-46A2-8B01-236C7BA6E3A0

P356

P1433

Movement Disorders

P1476

3-hydroxykynurenine and other ...... vered by metabolomic analysis.

@en

P2093

Arizona Parkinson's Disease Consortium

http://www.w3.org/2001/XMLSchema#string

Jia Li

http://www.w3.org/2001/XMLSchema#string

Lining Guo

http://www.w3.org/2001/XMLSchema#string

Mei Lu

http://www.w3.org/2001/XMLSchema#string

Peter A Lewitt

http://www.w3.org/2001/XMLSchema#string

P2860

Kynurenines in the mammalian brain: when physiology meets pathology

Organization of GC/MS and LC/MS metabolomics data into chemical libraries

Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

Analysis of metabolomic data using support vector machines.

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems.

Metabolomic profiling in LRRK2-related Parkinson's disease

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.

Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach.

P304

1653-1660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.25555

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Charles H Adler

P577

2013-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23873789

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease